NCCLS eNews - 8 March 2004 (Plain Text Version)Return to Graphical Version | Search back issues | Print all articles In this issue: Press Release: M36-A, Toxoplasma gondii
NCCLS Announces Availability of New NCCLS Document on Clinical Use and Interpretation of Serologic Tests for Toxoplasma gondii; Approved Guideline Individuals infected with the protozoan parasite, Toxoplasma gondii, generally show no detectable signs of infection and require no treatment. A small percentage of patients may require treatment, i.e., those with CNS toxoplasmosis or active ocular disease. However, if a woman becomes infected during pregnancy and the infection is passed to the fetus, the fetus may be catastrophically affected. These effects may be minimized or averted if Toxoplasma infection is diagnosed in a timely fashion and therapy instituted. NCCLS document M36-A is intended to aid laboratorians and physicians in determining the status of patients potentially infected with Toxoplasma gondii. Read the complete press release. View the complete listing of NCCLS press releases. For more information or to contact us directly, please visit www.nccls.org l ©2004 NCCLS |